Allarity Therapeutics
(NASDAQ) ALLR
Allarity Therapeutics Financials at a Glance
Market Cap
$19.77M
Revenue (TTM)
$320.00K
Net Income (TTM)
$11.23M
EPS (TTM)
$-0.79
P/E Ratio
-1.57
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Price
$1.38
Volume
6,264
Open
$1.27
Price
$1.38
Volume
6,264
Open
$1.27
Previous Close
$1.38
Daily Range
$1.27 - $1.42
52-Week Range
$0.77 - $2.35
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Price
$1.38
Volume
6,264
Open
$1.27
Previous Close
$1.38
Daily Range
$1.27 - $1.42
52-Week Range
$0.77 - $2.35
ALLR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Allarity Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Thomas H. Jensen
Website
www.allarity.comHeadquarters
Boston, MA 02139, US
ALLR Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-39%
Net Income Margin
-35%
Return on Equity
-104%
Return on Capital
-1%
Return on Assets
-62%
Earnings Yield
-63.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$19.77M
Shares Outstanding
15.82M
Volume
6.26K
Short Interest
0.00%
Avg. Volume
168.85K
Financials (TTM)
Gross Profit
$320.00K
Operating Income
$12.61M
EBITDA
$11.05M
Operating Cash Flow
$14.82M
Capital Expenditure
$8.00K
Free Cash Flow
$14.83M
Cash & ST Invst.
$14.69M
Total Debt
$1.40M
Allarity Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$320.00K
N/A
Gross Profit
$320.00K
N/A
Gross Margin
100.00%
N/A
Market Cap
$19.77M
N/A
Market Cap/Employee
$3.30M
N/A
Employees
6
N/A
Net Income
$3.37M
+54.7%
EBITDA
$3.31M
+55.2%
Quarterly Fundamentals
Net Cash
$13.29M
-26.9%
Accounts Receivable
$895.00K
-59.8%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$1.40M
+3.7%
Return on Assets
-61.51%
N/A
Return on Invested Capital
-1.28%
N/A
Free Cash Flow
$11.58M
+430.4%
Operating Cash Flow
$11.58M
+461.1%